Key Segments:
By Application
-
Medical Imaging and Diagnostics
-
Clinical Decision Support Systems
-
Remote Patient Monitoring
-
Hospital Workflow and Administrative AI
-
Others
By End Use
-
Hospitals
-
Diagnostics and Imaging Centers
-
Clinics
-
Ambulatory Surgery Centers
-
Others
By Component
-
Software
-
Hardware
-
Services
By Deployment Mode
-
Cloud-based
-
On-premises
-
Hybrid
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The market includes Tempus AI, Viz.ai, Aidoc, Qure.ai, Welldoc, Digital Diagnostics, Lunit, HeartFlow, Cleerly, Rad AI, Gleamer and Eko Health, among others. These companies compete on regulatory clearance breadth, platform scope and hospital and clinic purchasing relationships.
The main opportunities lie in expanding direct-to-consumer AI health platforms, tailoring lower-cost cloud-hosted applications for underserved markets with limited specialist access, and serving smaller clinics that are newly able to adopt cloud-based AI tools.
The key growth factor is rising regulatory clearance activity for AI-enabled medical devices combined with the availability of healthcare-tuned foundation model platforms, both of which are widening the range of vendors and applications hospitals can purchase.
By application, the Medical Imaging and Diagnostics segment dominated the market with approximately 36.80% share in 2025, supported by its early adoption lead and the broadest library of regulator-cleared indications.
North America dominated the market with approximately 38.90% share in 2025, supported by its dense base of hospitals, imaging networks and technology vendors. Asia Pacific is the fastest-growing region with a projected CAGR of 22.60% from 2026 to 2035.
